#MicromanipulatorSystems

[researchupdate]

High Incidence of Infertility and Government Initiatives to Boost Adoption of In-Vitro Fertilization to Augment Growth of Infertility Treatment Devices and Equipment (PDF Guideline)

The growth of the infertility treatment devices and equipmentmarket is mainly attributed to the increasing incidence of infertility in both sexes and rising number of fertility clinics and infertility services with government support. However, the high procedural cost of reproductive techniques hinders the market growth.

Fertility clinics are among medical clinics that support couples to gain fertility. Sometimes, individuals who want to conceive pregnancy but for medical reasons have been unable to achieve this goal through the natural course. There are several fertility clinics and services offered in the counties of NA and Europe to prevent infertility. Assisted reproductive technology (ART) now produces more than 50,000 babies per year in the US through 330,000 in vitro fertilization (IVF) procedures. Demand is growing from the ranks of more than seven million infertile women, many of which delayed childbearing due to careers. In the US, there are about 450 fertility clinics, more than 100 sperm banks, an unknown number of egg donors, and 1,700 reproductive endocrinologists competing for the business. IntegraMed and Prelude Fertility exist in the two large chains, as most programs are run by small M.D. practices or are part of a hospital or University. Various government initiatives and changes in the legal system drive the demand for assisted reproduction procedures in clinics. In the US, around 14 states cover infertility treatment under medical insurance. In Canada, the government is initiating measures to control the declining population, wherein it has sponsored various cycles of artificial insemination and IVF.

Click Here For More: https://www.businessmarketinsights.com/sample/TIPRE00016085?utm_source=Social&utm_medium=10457